The ETERNAL projects penultimate General Assembly Meeting, struck a positive and industrious note as the project partners gear up their activities and focus upon scale-up and adoption of Green Pharma innovation across the project’s six industrial case studies and supporting research into enhanced Environmental Risk Assessment and Digitalisation of Pharma processes and workflows.

Hosted at The University of Saarland over 12th and 13th March 2026, and in response to a successful second period review with the EU the meeting brought together representatives of the ETERNAL consortium’s sixteen partners to update one other on progress across the project’s work programme, and to galvanise the project’s approaches towards adoption-focused actions in the remaining months of the project, to define exploitation pathways for the project’s results supported by strong business cases.​​

The meeting heard that work is already underway to conduct scale-up risk assesments for the project’s six industrial case study demonstrations. These will be augmented with TRL-controlled milestones and regulatory checkpoints for each case study, reflecting amongst other things enhanced interaction with the EMA and JRC. ​Pivotal to success is deep integration across the project’s work packages, linking digitalization, pilots, and environmental data. ETERNAL is well set to provide strong foundations for this level of integration: the excellence of team alignment and consortium collaboration being reflected in the project’s 100% deliverable acceptance rate and milestone success to date.

The meeting also heard news of positive progress in the realm of intellectual property management and exploitation, with a first patent application underway as part of a robust overall plan for the project’s flagship exploitable results.

From Awareness to Practice

As the focus starts to transitions project outputs from awareness to practical, implementable solutions with real-world impact, the ETERNAL team didn’t waste any time upon returning from Germany to their respective homebases. In pursuit of aligning their outputs with the needs of stakeholders and regulatory requirements, a productive meeting was held online with the project’s External Stakeholder Group on 16th March. This yielded not valuable perspectives on Waste Management, Standardisation & Data Communication Management, and Digitalization & Social Campaigns, and how all these domains relate to environmental impact but also further expressions of interest from the water industry in ETERNAL’s advances in building a clearer picture on environmental risk and environmental fates of exemplar pharmaceutical substances.

ETERNAL will be showcasing its key results and achievements at its final dissmeination event, which will be taking place in Manchester, UK in the latter part of June. A firm dat ewill announced shortly, so watch this space!

To find out more about ETERNAL’s outputs and final dissemination activities…

Contact our friendly project co-ordinators at AIMPLAS